Related Experiment Videos
Ototoxic drugs and the detection of ototoxicity
The New England Journal of Medicine
|July 26, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects.
Diabetes, obesity & metabolism·2010
Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof-of-concept study in healthy subjects.
Clinical pharmacology and therapeutics·2009
A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects.
Diabetic medicine : a journal of the British Diabetic Association·2004
Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report.
Critical reviews in oncology/hematology·2001
Adoptive cellular immunotherapy for the treatment of malignant gliomas.
Critical reviews in oncology/hematology·2001
Lumbar stenosis: a clinical review.
Clinical orthopaedics and related research·2001
Pulmonary Nodules.
The New England journal of medicine·2026
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.
The New England journal of medicine·2026
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
The New England journal of medicine·2026
Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
The New England journal of medicine·2026
Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
The New England journal of medicine·2026
Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
The New England journal of medicine·2026
Multi-Omics Genome-Wide to Explore the Formation and Development Targets for Intracranial Aneurysms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Regulatory and Quality Considerations of Antibody-drug Conjugates.
AAPS PharmSciTech·2026
HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.
Nature communications·2026